Huntington's disease (HD) is a neurodegenerative disorder caused by the expansion of a CAG repeat in the IT15 gene that encodes the protein huntingtin (htt). Evidence shows that mutant htt causes mitochondrial depolarization and fragmentation, but the underlying molecular mechanism has yet to be clarified. Bax/Bak and BNip3 are pro-apoptotic members of the Bcl-2 family protein whose activation triggers mitochondrial depolarization and fragmentation inducing cell death. Evidence suggests that Bax/Bak and BNip3 undergo activation upon mutant htt expression but whether these proteins are required for mitochondrial depolarization and fragmentation induced by mutant htt is unclear. Our results show that BNip3 knock-out cells are protected from mitochondrial damage and cell death induced by mutant htt whereas Bax/Bak knock-out cells are not. Moreover, deletion of BNip3 C-terminal transmembrane domain, required for mitochondrial targeting, suppresses mitochondrial depolarization and fragmentation in a cell culture model of HD. Hence, our results suggest that changes in mitochondrial morphology and transmembrane potential, induced by mutant htt protein, are dependent and linked to BNip3 and not to Bax/Bak activation. These results provide new compelling evidence that underlies the molecular mechanisms by which mutant htt causes mitochondrial dysfunction and cell death, suggesting BNip3 as a potential target for HD therapy. †
Introduction
Huntington's disease (HD) is a neurodegenerative disorder caused by the expansion of a CAG tract in the IT15 gene that encodes the protein huntingtin (htt). The intracellular mechanisms by which mutant htt elicits neuronal cell death are not completely understood and no neuroprotective therapy exists. Extensive evidence shows that mutant htt induces loss of mitochondrial potential (ΔΨm) and fragmentation of mitochondrial tubular network (1) (2) (3) , but the underlying molecular mechanisms are still unclear. Evidence suggests that mutant htt promotes activation of certain pro-apoptotic BH3-only family proteins including Bax/Bak (4, 5) and Bcl-2/adenovirus E1B 19-kDa interacting protein 3 (BNip3) (6) . Bax is a cytosolic protein that, once activated, translocates into the outer mitochondrial membrane (OMM); here Bax, together with Bak, forms the apoptotic pore that is the point of no return in mitochondrial apoptosis (7) . Data from HD mouse models and human tissues converge to indicate that mutant htt expression causes Bax accumulation and translocation to the OMM (5, (8) (9) (10) but whether Bax/Bak activation is a key step of the mitochondrial depolarization and fragmentation induced by mutant htt is still unclear.
BNip3 is normally expressed in tissues as an inactive conformer (11) (12) (13) , and following toxic stimuli, it forms stable homodimers (14) , integrates into the OMM (12, 15, 16) and causes loss of ΔΨm and cell death. The unique structure of BNip3 transmembrane domain (TM) suggests that dimers of the protein could trigger mitochondrial OMM changes in a Bax/Bak-independent manner (16) (17) (18) or through formation of Bax/Bak channels (19, 20) .
Because both BNip3 and Bax/Bak accumulation causes mitochondrial depolarization (12, 16, 20) and fragmentation (17, (20) (21) (22) , consistent with HD phenotype (2, 23, 24) , we have tested the hypothesis that these proteins may be downstream effectors of mutant htt-induced mitochondrial dysfunction. Our data provide compelling new evidence that BNip3, but not Bax/Bak, plays a critical role in mitochondrial dysfunction and cell death induced by mutant htt, revealing a novel signaling axis.
Results

Bax/Bak double knock-out cells are susceptible to mitochondrial damage induced by mutant huntingtin
If Bax/Bak activation is a key step for mitochondrial damage induced by htt, then Bax/Bak knock-out cells should be protected from mitochondrial damages triggered by mutant htt. Thus, we tested the effects of mutant htt on mitochondrial depolarization and fragmentation in wild-type (wt) and Bax/Bak double knockout (DKO) mouse embryonic fibroblasts (MEFs). We transfected plasmids encoding wt htt (23 CAG) or mutant htt (73 CAG and 145 CAG) in wt MEFs and measured ΔΨm by TMRM fluorescence. Wt htt did not affect TMRM fluorescence in wt and Bax/Bak DKO MEFs (mean ± SEM: empty plasmid 100 ± 7.83 versus wt htt 92.99 ± 8.24 in wt MEFs; empty plasmid 100 ± 6.00 versus wt htt 103. 16 ± 5.26 in Bax/Bak DKO MEFs, P > 0.05, One-way ANOVA and Tukey test) whereas mutant htt induced ΔΨm loss both in wt MEFs (mean ± SEM: 73 CAG htt 61.50 ± 2.7 and 145 CAG htt 41.02 ± 1.41, P < 0.001 versus empty plasmid and wt htt, F = 25.94, One-way ANOVA and Tukey test) and in Bax/Bak DKO MEFs (mean ± SEM: 73 CAG htt 50.18 ± 2.72 and 145 CAG htt 42.86 ± 2.37, P < 0.001 versus empty plasmid and wt htt, F = 54.19, One-way ANOVA and Tukey test; Fig. 1A ).
Because mitochondrial depolarization induces mitochondrial fission (25), we next analyzed mitochondrial fragmentation by co-transfecting plasmids encoding htt and a plasmid encoding mitochondrially targeted fluorescent protein ( pDsRed2-Mito). Double transfected cells were analyzed for an automated shape-analysis of the mitochondrial structures (26): for each mitochondrial particle, we determined the aspect ratio (AR), a measure of length (27, 28) , and the form factor (FF), a measure of length and degree of branching (27, 29) .
Wt htt did not induce mitochondrial fragmentation in wt MEFs and in Bax/Bak DKO MEFs (AR medians ± 25%: empty plasmid 2.02 ± 1.54 and wt htt 2.08 ± 1.59 in wt MEFs; empty plasmid 1.94 ± 1.55 and wt htt 2.08 ± 1.56 in Bax/Bak DKO MEFs; FF medians ± 25%: empty plasmid 1.62 ± 1.24 and wt htt 1.69 ± 1.25 in wt MEFs; empty plasmid 1.55 ± 1.15 and wt htt 1.61 ± 1.17 in Bax/Bak DKO MEFs, P > 0.05, Kruskal-Wallis ANOVA on Ranks). Mutant htt decreased both AR and FF in wt MEFs (AR medians ± 25%: 73 CAG htt 1.77 ± 1.46 and 145 CAG htt 1.82 ± 1.46, P < 0.001 versus empty plasmid and wt htt, Kruskal-Wallis ANOVA on Ranks; FF medians ± 25%: 73 CAG htt 1.34 ± 1.07 and 145 CAG htt 1.46 ± 1.11, P < 0.001 versus empty plasmid and wt htt, KruskalWallis ANOVA on Ranks) and in Bax/Bak DKO MEFs (AR medians ± 25%: 73 CAG htt 1.82 ± 1.46 and 145 CAG htt 1.68 ± 1.39, P < 0.001 versus empty plasmid and wt htt, Kruskal-Wallis ANOVA on Ranks; FF medians ± 25%: 73 CAG htt 1.44 ± 1.14, P = 0.038 versus empty plasmid and P = 0.022 versus wt htt; 145 CAG htt1.31 ± 1.06, P < 0.001 versus empty plasmid and wt htt, Kruskal-Wallis ANOVA on Ranks; Fig. 1B ).
Given that mutant htt induces mitochondrial depolarization, fragmentation and cell death (30), we analyzed cell viability in wt MEFs and Bax/Bak DKO MEFs transfected with wt or mutant human htt. In both cell types, overexpression of wt htt did not change cell death rate (% of death/total cells ± SEM: empty plasmid 1.20 ± 0.17 versus wt htt 0.81 ± 0.13 in wt MEFs; empty plasmid 0.09 ± 0.04 versus wt htt 0.25 ± 0.11 in Bax/Bak DKO MEFs, P > 0.05, One-way ANOVA and Tukey test). Conversely, mutant htt increased cell death rate in wt MEFs and Bax/Bak DKO MEFs (% of death/total cells ± SEM: 73 CAG htt 5.15 ± 0.52 and 145 CAG htt 3.86 ± 0.59, P < 0.001 versus empty plasmid and wt htt in wt MEFs; 73 CAG htt 1.85 ± 0.30, P < 0.001 versus empty plasmid and wt htt; 145 CAG htt 1.52 ± 0.29, P < 0.01 versus empty plasmid and wt htt in Bax/Bak DKO MEFs, F = 15.80, One-way ANOVA with Tukey test; Fig. 1C ). These results show that Bax/Bak DKO MEFs, as wt MEFs, are susceptible to mitochondrial depolarization, fragmentation and cell death induced by mutant htt. This result suggests that mutant htt elicits mitochondrial damage and cell death through a molecular pathway that is independent on Bax/Bak activation.
BNip3 knock-out cells are protected from mitochondrial damage induced by mutant huntingtin Evidence shows that mutant htt induces BNip3 activation (6) . We thought that if BNip3 activation is a key step in the molecular pathway by which mutant htt induces mitochondrial damage, then BNip3 knock-out cells should be protected from mitochondrial damages induced by mutant htt.
Thus, we investigated ΔΨm and mitochondrial fragmentation in wt and BNip3 knock-out (KO) MEFs (17, 31) One-way ANOVA and Tukey test). Conversely, mutant htt did not depolarize mitochondria of BNip3 KO MEFs (mean ± SEM: 73 CAG htt 97.83 ± 7.38, 145 CAG htt 106.97 ± 8.00, P > 0.05 versus empty plasmid and wt htt, F = 0.25, One-way ANOVA and Tukey test; Fig. 2A ).
Because this result suggested that BNip3 KO MEFs are protected from mitochondrial depolarization induced by mutant htt, we hypothesized that BNip3 KO MEFs could also be protected from mutant htt-induced mitochondrial fragmentation. Therefore, we transfected wt and BNip3 KO MEFs with wt or mutant htt and calculated for each mitochondrial particle AR and FF values. Wt htt did not modify AR and FF in wt MEFs and BNip3 KO MEFs (AR medians ± 25%: empty plasmid 2.02 ± 1.54 and wt htt 2.08 ± 1.59 in wt MEFs; empty plasmid 1.91 ± 1.49 and wt htt 1.83 ± 1.45 in BNip3 KO MEFs; FF medians ± 25%: empty plasmid 1.62 ± 1.24 and wt htt 1.69 ± 1.25 in wt MEFs; empty plasmid 1.45 ± 1.10 and wt htt 1.38 ± 1.03 in BNip3 KO MEFs, P > 0.05, Kruskal-Wallis ANOVA on Ranks). Mutant htt decreased AR and FF values in wt MEFs (AR medians ± 25%: 73 CAG htt 1.77 ± 1.46 and 145 CAG htt 1.82 ± 1.46, P < 0.001 versus empty plasmid and wt htt, Kruskal-Wallis ANOVA on Ranks; FF medians ± 25%: 73 CAG htt 1.34 ± 1.07 and 145 CAG htt 1.46 ± 1.11, P < 0.001 versus empty plasmid and wt htt, Kruskal-Wallis ANOVA on Ranks). Conversely, mutant htt expression did not modify AR and FF in BNip3 KO MEFs (AR medians ± 25%: 73 CAG htt 1.85 ± 1.46 and 145 CAG htt 1.86 ± 1.46 versus empty plasmid and wt htt, P > 0.05, KruskalWallis ANOVA on Ranks; FF medians ± 25%: 73 CAG htt 1.43 ± 1.09 and 145 CAG htt 1.39 ± 1.06 versus empty plasmid and wt htt, P > 0.05, Kruskal-Wallis ANOVA on Ranks; Fig. 2B ). These results showed that BNip3 KO MEFs are resistant to mitochondrial depolarization and fragmentation induced by mutant htt and suggested that BNip3 KO MEFs can be protected by mutant httinduced cytotoxicity.
Thus, we examined cell viability in wt and BNip3 KO MEFs transfected with plasmids encoding human htt. As expected, mutant htt protein significantly increased cell death rate in wt MEFs (% of death/total cells ± SEM 48 h after transfection: 73 CAG htt 5.15 ± 0.52 and 145 CAG htt 3.86 ± 0.59, P < 0.001 versus empty plasmid 1.20 ± 0.17 and wt htt 0.81 ± 0.13, F = 18.99, Oneway ANOVA and Tukey test; Fig. 2C ). Conversely, mutant htt did not increase cell death rate in BNip3 KO MEFs (% of death/total cells ± SEM 48 h after transfection: 73 CAG htt 1.52 ± 0.40 and 145 CAG htt 1.07 ± 0.28 versus empty plasmid 0.99 ± 0.23 and wt htt 0.98 ± 0.22, P > 0.05, One-way ANOVA and Tukey test). Cell death rate was significantly lower in BNip3 KO MEFs compared with wt MEFs expressing 73 CAG (48 h after transfection wt MEFs 5.15 ± 0.52, P < 0.001 versus BNip3 KO 1.52 ± 0.40, F = 18.99, One-way ANOVA and Tukey test) or 145 CAG htt (48 h after transfection wt MEFs 3.86 ± 0.59, P < 0.001 versus BNip3 KO 1.07 ± 0.28, One-way ANOVA and Tukey test; Fig. 2C ). Viability assay was also performed 72 h after transfection and confirmed that mutant htt did not induce cell death in BNip3 KO MEFs (Supplementary Material, Fig. S1 ).
To further confirm BNip3 crucial role in mutant htt-induced cytotoxicity, we co-transfected BNip3 KO MEFs with a plasmid encoding BNip3 together with wt or mutant htt.
BNip3 KO cells expressing htt plasmid alone showed no significant variations in the rate of death among the different conditions (% of death/total cells ± SEM: 73 CAG htt 0.32 ± 0.21 and 145 CAG htt 0.27 ± 0.18 versus empty plasmid 0.32 ± 0.21 and wt htt 0.29 ± 0.20, P > 0.05, One-way ANOVA and Tukey test), whereas when BNip3 was reintroduced in BNip3 KO MEFs, the presence of mutant htt led to an increased mortality (% of death/total cells ± SEM: 73 CAG htt 4.74 ± 0. 35 Fig. 2C ). Overall, these experiments show that the absence of BNip3 protects MEFs from mitochondrial depolarization and fragmentation and from cell death triggered by mutant htt and suggest a central role for BNip3 activation in the mitochondrial alteration induced by mutant htt.
BNip3 blocking rescues mitochondrial potential and fragmentation in HD cell culture model
The C-terminal TM of BNip3 is critical for its homodimerization and mitochondrial integration because deletion of this domain (BNip3ΔTM) prevents BNip3 insertion into the OMM, dimers formation and cell death induction (12, 18, 21, 32, 33) . As Figure 2 demonstrates, the absence of BNip3 protects cells from mutant htt-induced mitochondrial damage; therefore, we hypothesized that BNip3 blocking by the expression of the dominant-negative mutant BNip3ΔTM can rescue mitochondrial damage in the HD cell culture model STHdh Q111/Q111 (34 Fig. 3C ). These results showed that BNip3ΔTM expression increases the continuity of mitochondrial network in STHdh Q111/Q111 cells and confirmed the results of Figure 3B .
Taken together these data suggest that BNip3 blocking decreases mitochondrial damage induced by mutant htt.
Discussion
This paper provides new knowledge in the field of HD pathogenesis by producing the following three important novelties: (1) Bax/Bak DKO cells are not protected from mitochondrial damage induced by mutant htt, (2) BNip3 KO cells are protected from mitochondrial damage induced by mutant htt and (3) the dominant-negative BNip3ΔTM rescues mitochondrial damage in HD cells. Because Bax/Bak levels and localization modulate the mitochondrial apoptotic pathway and influence mitochondrial fission-fusion dynamics (39, 40) , these proteins have long been investigated in HD models (41) . In vitro studies provided controversial evidence about Bax/Bak in HD (41): mutant htt elicits accumulation of Bax protein (8) and Bax translocation from the cytosol to the OMM in some cell culture models (9) whereas, in other models, mutant htt induces Bax-independent cell death (4). In vivo studies in HD mouse models support the theory that mutant htt expression causes Bax protein accumulation and Bax translocation to the OMM (4,5,10,42), whereas Bak levels were found equal in tissues of HD mouse models and littermate controls (42) . Hence, whether Bax/Bak intervene in the pathogenic pathway induced by mutant htt is still unclear. Our results show that mutant htt can induce mitochondrial depolarization, fragmentation and cell death independently of Bax/Bak expression, thus suggesting that Bax/Bak activation is not mandatory for htt-induced mitochondrial damage. Conversely, according to our results, mutant htt does not induce mitochondrial depolarization, fragmentation and cell death in BNip3 KO MEFs, thus suggesting that htt needs BNip3 protein activation to induce mitochondrial damage. How does mutant htt induce BNip3 activation? We do not have the knowledge nowadays to certainly answer this question. It has been shown that wild-type htt supports a high level of active nuclear factor κ light-chain-enhancer of activated B cells (NF-κB) in neuronal nuclei and that this function is impaired by the polyQ expansion (43) . Because BNip3 is strongly transcriptionally silenced by NF-κB (44,45), we can hypothesize that mutant htt increases BNip3 mRNA levels. Nevertheless, previous findings showing that mutant htt increases BNip3 colocalization with mitochondria (6) argue in favor of a post-translational mechanism. As BNip3 undergoes several phosphorylation events at its C-terminus and phosphorylation at these residues inhibits BNip3-induced mitochondrial damage (46, 47) , we can speculate that mutant htt modifies BNip3 phosphorylation through impairing kinase signaling pathway (48) . Future studies will clarify the molecular mechanisms by which mutant htt induce BNip3 activation; the present study provides reliable evidence that changes in mitochondrial morphology and transmembrane potential, induced by mutant htt protein, are dependent and linked to BNip3 activation.
Once activated BNip3 can induce mitochondrial damage through at least two distinct mechanisms: BNip3 can engage anti-apoptotic Bcl-2 family members to trigger Bax/Bak-dependent OMM permeability (49) or can modify the fusion-fission balance of mitochondrial networks by interacting with pro-fusion or profission proteins. Showing that mutant htt toxicity is independent on Bax/Bak expression, we can speculate that BNip3 promotes mitochondria fragmentation by inhibiting pro-fusion proteins or activating pro-fission proteins. Because our data show that BNip3ΔTM rescues mitochondrial fragmentation in HD cells, our study agrees with previous results showing that TM domain of BNip3 interacts with the pro-fusion protein Optic atrophy-1 (Opa1) and inhibits mitochondrial fusion (22) . Equally important, BNip3 may modify the function of the pro-fission protein Dynamin-related protein 1 (Drp1). Because evidence suggests that BNip3 induces Drp1 translocation to mitochondria in cardiac myocytes (50) and evidence shows an abnormal activation of Drp1 in HD cells (3, (51) (52) (53) , we can speculate that BNip3 induces Drp1 translocation to mitochondria in HD neurons. Yet, it is conceivable that BNip3 induces mitochondrial damage in HD cells by participating in a molecular pathway that is independent on Drp1 activation. In this context, it is important to remember that a structural study performed on bilayer lipid membranes highlighted that BNip3 alone form an ion-conducting pathway in the membrane (14) . This experimental evidence, together with structural bioinformatics analyses (54) , suggests that BNip3 alone can initiate the permeability of the mitochondrial outer membrane and induces ΔΨm loss. Future studies will address the mechanism by which BNip3 activation induces mitochondrial damage in HD cells. Future studies will also clarify whether BNip3 protein, being a member of Bcl-2 family proteins, already molecular targets in cancer therapy (55) , may be also a therapeutic target for HD.
Materials and Methods
Cell cultures
STHdh Q7/Q7 and STHdh Q111/Q111 , striatal cell lines derived from knock-in mice expressing full-length wt htt carrying 7 CAG repeats or 111 CAG repeats, respectively (34), were maintained in high glucose DMEM (Dulbecco's modified Eagle's medium) supplemented with 10% FBS and 400 μg/ml G418. To induce mitochondrial stress, cells were incubated in glucose-free RPMI 1640 medium supplemented with 10% FBS, 5 m pyruvate, 5 m galactose and 400 μg/ml G418.
Wt, BNip3 KO and Bax/Bak DKO MEFs were maintained in DMEM supplemented with 5% FBS. Then, cells were washed with PBS and fixed with 4% paraformaldehyde, coverslips were mounted with ProLong mounting with DAPI (Life Technologies, P36931) and images were acquired at confocal microscope (Nikon Eclipse C1).
Mitochondrial morphology assay
MEF cells (wt, BNip3 KO and Bax/Bak DKO) were plated on collagen-coated coverslips at a density of 2.5 × 10 4 . Cells were cotransfected with pDsRed2-Mito and pcDNA3 empty plasmid or pcDNA3 expressing full-length wt htt, or 73 CAG or 145 CAG repeats htt, using Effectene Transfection Reagent (Qiagen, 301425). Cells were washed with PBS and fixed with 4% paraformaldehyde 48 h after transfection; nuclei were stained with Hoechst (Thermo Scientific, 33342). Coverslips were mounted with FluoroSave Reagent (Millipore, 345789) and images were acquired by confocal microscopy (Carl Zeiss Axio Observer SD).
Using ImageJ software, raw images were binarized, and mitochondria were subjected to automated particle analyses to obtain, for each mitochondrial particle, values for aspect ratio (AR: major axis/minor axis), a measure for mitochondrial length (27, 28) and form factor (FF: perimeter 2 /4π·Area), a measure of length and branching (27, 29) . Both AR and FF are independent of image magnification and have a minimum value of 1, corresponding to a circular mitochondrion; values increase with mitochondrial elongation.
FRAP
STHdh Q7/Q7 and STHdh Q111/Q111 cells, plated on 35-mm cover glass bottom dishes, coated with poly--lysine, were co-transfected with pDsRed2-Mito and p305-GFP empty plasmid or p305-GFP-BNip3ΔTM, using Lipofectamine 2000, following manufacturer's instructions. After transfection, cells were shifted at 39°C and incubated in the stress medium for 72 h.
FRAP experiments were performed at 39°C, maintaining the cells in glucose-free, phenol red-free DMEM supplemented with 5 m galactose. The experiments were performed using a confocal microscope (Leica Microsystems, TCS SP5 AOBS) equipped with a microscope incubator (Okolab) on cells co-expressing both the transfected constructs.
pDsRed2-Mito was photobleached in a cytoplasmic ROI, and fluorescence recovery was followed for 90 s. At each time point, the mean fluorescence in the ROI (F ROI(t) ) was corrected for the background fluorescence (F bg(t) ) and normalized for the mean fluorescence of an ROI that was not subjected to photobleaching (F noPB(t) ) subtracted of background fluorescence (F bg(t) ), to correct for the photobleaching of pDsRed2-Mito owing to the imaging procedure: F (t) = [F ROI(t) −F bg(t) ]/[F noPB(t) −F bg(t) ].
Finally, background and photobleaching-corrected fluorescence values were normalized for the fluorescence value measured just before photobleaching (F prePB ): f norm(t) = F (t) /F prePB .
Viability assay
MEFs (wt, BNip3 KO, Bax/Bak DKO), plated on collagen-coated coverslips at a density of 3 × 10 4 , were transfected with pcDNA3 empty plasmid or pcDNA3 expressing full-length wt htt, or 73 CAG or 145 CAG repeats htt or co-transfected with the htt plasmids and pcDNA3 expressing BNip3 or empty (as control condition), using Effectene Transfection Reagent. Cells were assessed for viability 48-72 h after transfection, by staining with 3.2 µ Calcein AM (green, living cells) and 0.6 µ Ethidium homodimer-1 (red, dead cells) (Live/Dead Viability/ Cytotoxicity kit, Life Technologies, L3224) for 30 min at 37°C in the dark. Coverslips were mounted on glass slides and images acquired using an epifluorescence microscope (Olympus Provis AX70 Research grade microscrope).
Mitochondrial membrane potential
MEFs (wt, BNip3 KO, Bax/Bak DKO), plated on collagen-coated coverslips at a density of 2.5 × 10 4 , were transfected with pcDNA3 empty plasmid or pcDNA3 expressing full-length wt htt, or 73 CAG or 145 CAG repeats htt, using Effectene Transfection Reagent. Mitochondrial membrane potential was measured 48 h after transfection, by staining with 0.4 µ Tetramethylrhodamine, methyl ester (TMRM, Life Technologies, T668) (56) for 30 min at 37°C in the dark. Coverslips were then mounted on glass slides and images were acquired using an epifluorescence microscope (Olympus Provis AX70 Research grade microscope). STHdh Q7/Q7 and STHdh Q111/Q111 cells, plated on 35-mm cover glass bottom dishes, coated with poly--lysine, were transfected with p305-GFP empty plasmid or p305-GFP-BNip3ΔTM using Lipofectamine 2000. After transfection, cells were shifted at 39°C and incubated in the stress medium for 72 h. Then cells were assessed for mitochondrial membrane potential by staining with 0.4 µ TMRM for 30 min at 37°C in the dark. Images were acquired by confocal microscopy (Nikon Eclipse C1).
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